515 . Haider N, et al. J Clin Invest. 2021 Sep 10:151818. doi: 10.1172/JCI151818. Online ahead of print. J Clin Invest. 2021. PMID: 34506305 . Mol Ecol Resour. 2014 May;14(3):606-15. doi: 10.1111/1755-0998.12205. Epub 2013 Dec 30. Mol Ecol Resour. 2014. PMID: 24266987 . Cite . What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? Petrini P. Petrini P. Page Menu News Page Menu News Gluten intolerance a significant risk factor Infectious disease of the uterus Absence of an individual specific disease Page Menu News